PAR 0.00% 19.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm receives clarity on US regulatory pathway, page-20

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,303 Posts.
    lightbulb Created with Sketch. 296
    Days are not, as far as I can see. No timeline on replying to FDA that we've been told about. No timeline for spening the money. Trial finish pushed out by a year so don't see the hurry to sell the company at $130 with no reference to retail holders. I still believe and will hold - what I am saying is that this is not like the company we've been investing in - so I want an explanation to make me feel better. It's like when the government screws me - and doesn't take me to dinner first!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.